Inventor
KNOPF JOHN
US80 patents
⚠️ This page may combine multiple inventors who share the name “KNOPF JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ACCELERON PHARMA INC
33 patentsUS8343933B2Jan 1, 2013
Variants derived from ActRIIB and uses therefor
ACCELERON PHARMA INC91 citations99
US7842663B2Nov 30, 2010
Variants derived from ActRIIB and uses therefor
ACCELERON PHARMA INC135 citations99
US7709605B2May 4, 2010
ActRII receptor polypeptides, methods and compositions
ACCELERON PHARMA INC145 citations99
US7612041B2Nov 3, 2009
Isolated activin-binding ActRIIa polypeptide comprising the SEQ ID NO: 7 and uses for promoting bone growth
ACCELERON PHARMA INC132 citations99
US7960343B2Jun 14, 2011
Activin-ActRIIa antagonists and uses for decreasing or inhibiting FSH secretion
ACCELERON PHARMA INC48 citations98
US7951771B2May 31, 2011
Activin-ActRIIa antagonists and uses for promoting bone growth
ACCELERON PHARMA INC56 citations98
US10722558B2Jul 28, 2020
Compositions and methods for treating pulmonary hypertension
ACCELERON PHARMA INC15 citations94
US10695405B2Jun 30, 2020
Compositions and methods for treating pulmonary hypertension
ACCELERON PHARMA INC13 citations94
US10259861B2Apr 16, 2019
Variants derived from ActRIIB and uses therefor
ACCELERON PHARMA INC22 citations94
US9399669B2Jul 26, 2016
Variants derived from ActRIIB
ACCELERON PHARMA INC27 citations94
US9353356B2May 31, 2016
Activin-actriia antagonists for treating a follicle-stimulating horomone-secreting pituitary tumor
ACCELERON PHARMA INC36 citations94
US8367611B2Feb 5, 2013
Activin-actriia antagonists for inhibiting germ cell maturation
ACCELERON PHARMA INC35 citations94
US9163075B2Oct 20, 2015
Isolated polynucleotide that encodes an ActRIIa-Fc fusion polypeptide
ACCELERON PHARMA INC20 citations93
US7807631B2Oct 5, 2010
Methods of promoting growth of muscle tissue using ALK7
ACCELERON PHARMA INC15 citations93
US7316998B2Jan 8, 2008
Cerberus/Coco derivatives and uses thereof
ACCELERON PHARMA INC16 citations93
US11622992B2Apr 11, 2023
Compositions and methods for treating pulmonary hypertension
ACCELERON PHARMA INC3 citations84
US11219666B2Jan 11, 2022
Compositions and methods for treating pulmonary hypertension
ACCELERON PHARMA INC5 citations84
US11065303B2Jul 20, 2021
Compositions and methods for treating pulmonary hypertension
ACCELERON PHARMA INC6 citations84
US11028145B2Jun 8, 2021
ALK7:actriib heteromultimers and uses thereof
ACCELERON PHARMA INC4 citations84
US10973880B2Apr 13, 2021
Compositions and methods for treating pulmonary hypertension
ACCELERON PHARMA INC7 citations84
US10946067B2Mar 16, 2021
Compositions and methods for treating pulmonary hypertension
ACCELERON PHARMA INC6 citations84
US10071135B2Sep 11, 2018
Method of identifying an agent that promotes bone growth or increases bone density
ACCELERON PHARMA INC6 citations84
US9790284B2Oct 17, 2017
Methods for increasing thermogenic adipocytes
ACCELERON PHARMA INC5 citations84
US7456149B2Nov 25, 2008
ALK7 and myostatin inhibitors and uses thereof
ACCELERON PHARMA INC11 citations84
US9809636B2Nov 7, 2017
Methods for increasing red blood cell levels comprising administering BMP9
ACCELERON PHARMA INC8 citations82
US10968282B2Apr 6, 2021
Methods for screening compounds for increasing thermogenic adipocytes
ACCELERON PHARMA INC2 citations73
US10227392B2Mar 12, 2019
ALK7:ActRIIB heteromultimers and uses thereof
ACCELERON PHARMA INC3 citations73
US11059894B2Jul 13, 2021
ALK7 binding proteins and uses thereof
ACCELERON PHARMA INC1 citations72
US10501547B2Dec 10, 2019
ALK7 binding proteins and uses thereof
ACCELERON PHARMA INC3 citations72
US10344066B2Jul 9, 2019
Methods and compositions for increasing red blood cells
ACCELERON PHARMA INC3 citations71
US12343378B2Jul 1, 2025
Compositions and methods for treating pulmonary hypertension
ACCELERON PHARMA INC0 citations63
US11497794B2Nov 15, 2022
Compositions and methods for treating pulmonary hypertension
ACCELERON PHARMA INC0 citations63
US11318188B2May 3, 2022
Compositions and methods for treating pulmonary hypertension
ACCELERON PHARMA INC0 citations63
KNOPF JOHN
11 patentsUS8178488B2May 15, 2012
Methods for increasing thermogenic adipocytes
KNOPF JOHN92 citations99
US8703694B2Apr 22, 2014
Methods for increasing thermogenic adipocytes
KNOPF JOHN43 citations98
US8629109B2Jan 14, 2014
Method for promoting bone growth using activin-actriia antagonists
KNOPF JOHN57 citations98
US8252900B2Aug 28, 2012
Actriib-Fc polynucleotides, polypeptides, and compositions
KNOPF JOHN92 citations98
US8128933B2Mar 6, 2012
Method of promoting bone growth by an anti-activin B antibody
KNOPF JOHN49 citations98
US8067360B2Nov 29, 2011
Method for promoting bone growth using activin-ActRIIa antagonists
KNOPF JOHN59 citations98
US9526759B2Dec 27, 2016
Activin-actriia antagonists and uses for treating or preventing breast cancer
KNOPF JOHN38 citations94
US8173601B2May 8, 2012
Activin-ActRIIa antagonists and uses for treating multiple myeloma
KNOPF JOHN42 citations94
US9572865B2Feb 21, 2017
Activin-actriia antagonists and uses for treating multiple myeloma
KNOPF JOHN16 citations93
US9138459B2Sep 22, 2015
ACTRIIB-FC polynucleotides, polypeptides, and compositions
KNOPF JOHN26 citations93
US8486403B2Jul 16, 2013
Method of promoting bone growth by an anti-activin A antibody
KNOPF JOHN4 citations74
GRINBERG ASYA
3 patentsUS8455428B2Jun 4, 2013
ALK1 receptor and ligand antagonist and uses thereof
GRINBERG ASYA8 citations83
US8158584B2Apr 17, 2012
Pharmaceutical preparations comprising an ALK1-Fc fusion protein
GRINBERG ASYA10 citations82
US10059756B2Aug 28, 2018
Compositions comprising ALK1-ECD protein
GRINBERG ASYA3 citations71
SEEHRA JASBIR
2 patentsWYETH CORP
1 patentShowing the top 50 of 80 patents by PatentIndex Score.